The Wisconsin Hepatitis C Program is the lead agency in Wisconsin responsible for coordinating the state's public health activities related to the prevention, detection, and treatment of hepatitis C.
Important Information for Consumers:
Important Information for Health Care Professionals:
A new cohort of young injection drug users acquiring HCV infection has been recognized in Wisconsin and nationwide, notably in suburban and rural areas. This article, published in the April 11, 2014 Morbidity and Mortality Week Report (MMWR), describes the use of rapid hepatitis C virus (HCV) testing as an important tool for conducting HCV screening, imparting prevention information, and initiating treatment in a population with high prevalence of HCV infection. The article is available on the web at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6314a3.htm.
Medical Societies Launch New Hepatitis C Treatment Guidelines
On January 29, 2014, the American Association for the Study of Liver Diseases (AASLD), Infectious Diseases Society of America (IDSA), and International Antiviral Society-USA (IAS-USA) released the first new hepatitis C treatment guidelines to include the recently approved next-generation direct-acting antiviral agents. The guidance, which will be updated frequently, is available on the web at HCVguidelines.org. Printable version of the guidelines http://www.hcvguidelines.org/sites/default/files/full_report.pdf.
Researchers from the Yale Schools of Medicine and Public Health found that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature resulting in a longer period for potential transmission of HCV than previously thought. More information http://blog.aids.gov.
Healthiest Wisconsin 2020 Baseline and Health Disparities Report
This new report provides baseline data for the health focus areas in Healthiest Wisconsin 2020. It also provides information to document a range of health disparities found for some of the populations and communities in Wisconsin.